Zelda Therapeutics ready to test 'entourage effect' hypothesis in cancer research



Zelda Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF) executive chairman Harry Karelis tells Proactive Investors the medical cannabis researcher’s latest news.

Be the first to comment

Leave a Reply

Your email address will not be published.


*